Non-Urothelial Bladder Cancer: Difference between revisions

Revision as of 10:55, 17 December 2021

Type of neuroendocrine histology
Should be considered and treated as metastatic disease, even if there is no radiologic evidence of disease outside the bladder
In general, primary small cell carcinoma of the bladder is very chemosensitive
Primary mode of therapy is chemoradiation therapy; chemotherapy and radical cystectomy is an option with similar survival (5-year CSS 16% chemoradiation vs. 18% chemotherapy and radical cystectomy)
Primary method to improve survival will be more effective systemic therapy

Subclassification of sarcoma is based on histologic variations, depending on the specific malignant cell type
Leiomyosarcoma is the most common histologic subtype, followed by rhabdomyosarcoma and then, rarely, angiosarcoma, osteosarcoma, and carcinosarcoma

Wein AJ, Kavoussi LR, Partin AW, Peters CA (eds): CAMPBELL-WALSH UROLOGY, ed 11. Philadelphia, Elsevier, 2015, chap 92

Revision as of 10:20, 17 December 2021 edit Urology4all (talk \| contribs) Bureaucrats, Interface administrators, Administrators 6,859 edits Created page with "== Small cell carcinoma of the bladder == * '''Type of neuroendocrine histology''' * '''Should be considered and treated as metastatic disease, even if there is no radiologic evidence of disease outside the bladder''' * In general, primary small cell carcinoma of the bladder is '''very chemosensitive''' * '''Primary mode of therapy is chemoradiation therapy; chemotherapy and radical cystectomy is an option with similar survival''' (5-year CSS 16% chemoradiation vs. 18%..." Tag: Visual edit		Revision as of 10:55, 17 December 2021 edit undo Urology4all (talk \| contribs) Bureaucrats, Interface administrators, Administrators 6,859 edits No edit summary Newer edit →
Line 1:		Line 1:
			[[Category:Bladder Cancer]]

	== Small cell carcinoma of the bladder ==		== Small cell carcinoma of the bladder ==